Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
The Oncologist|April 16, 2022
Multicenter Real-World Study on Effectiveness and Early Discontinuation Predictors in Patients With Non-small Cell Lung Cancer Receiving NivolumabGiulia Pasello, Martina Lorenzi, Lorenzo Calvetti, et al.European Journal of Cancer (Oxford, England : 1990)|April 10, 2022
Clinical profile and mortality of Sars-Cov-2 infection in cancer patients across two pandemic time periods (Feb 2020-Sep 2020; Sep 2020-May 2021) in the Veneto Oncology Network: The ROVID studyMaria V Dieci, Giuseppe Azzarello, Vittorina Zagonel, et al.The Oncologist|March 9, 2019
From Diagnostic-Therapeutic Pathways to Real-World Data: A Multicenter Prospective Study on Upfront Treatment for EGFR-Positive Non-Small Cell Lung Cancer (MOST Study)Giulia Pasello, Giovanni Vicario, Fable Zustovich, et al.Cancer|September 21, 2016
Whole-exome sequencing and targeted gene sequencing provide insights into the role of PALB2 as a male breast cancer susceptibility geneValentina Silvestri, Veronica Zelli, Virginia Valentini, et al.Oncology|September 15, 2007
Feasibility of sequential therapy with FOLFIRI followed by docetaxel/cisplatin in patients with radically resected gastric adenocarcinoma. A randomized phase III trialMaria Di Bartolomeo, Roberto Buzzoni, Luigi Mariani, et al.European Journal of Cancer (Oxford, England : 1990)|March 1, 2021
Epidemiology and clinical course of severe acute respiratory syndrome coronavirus 2 infection in cancer patients in the Veneto Oncology Network: The Rete Oncologica Veneta covID19 studyValentina Guarneri, Franco Bassan, Vittorina Zagonel, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 22, 2022
Delphi Initiative for Early-Onset Colorectal Cancer (DIRECt) International Management GuidelinesGiulia Martina Cavestro, Alessandro Mannucci, Francesc Balaguer, et al.Breast Cancer Research : BCR|February 22, 2012
Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriersAntonis C Antoniou, Karoline B Kuchenbaecker, Penny Soucy, et al.Journal of the National Cancer Institute|November 21, 2015
BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian CancersHuong D Meeks, Honglin Song, Kyriaki Michailidou, et al.Pageof 3